Endothelium-derived hyperpolarization factor (EDHF) is up-regulated in a pig model of acute liver failure

Scandinavian Journal of Gastroenterology

Volumn 42, Issue 3, 2007, Pages 356-365

  Ekse, Sveinung ^a   Clapp, Lucie H ^b   Revhaug, Arthur ^a   Ytrebø, Lars Marius ^a,c  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

Hemodynamics; Isometric force; K+ channels; Nitric oxide; Vascular smooth muscle

Indexed keywords

APAMIN; CALCIUM ACTIVATED POTASSIUM CHANNEL; CHARYBDOTOXIN; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; HEME OXYGENASE INHIBITOR; NITRIC OXIDE SYNTHASE INHIBITOR; PHENYLEPHRINE; POTASSIUM CHANNEL BLOCKING AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY DILATATION; ARTERY RESISTANCE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; EXPERIMENTAL MODEL; FEMALE; FEMORAL ARTERY; FEMORAL ARTERY FLOW; HEART INDEX; HEMODYNAMICS; LIVER BLOOD FLOW; LIVER FAILURE; LIVER ISCHEMIA; MEAN ARTERIAL PRESSURE; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; SWINE; UPREGULATION; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ANALYSIS OF VARIANCE; ANIMALS; APAMIN; BIOLOGICAL FACTORS; BLOOD PRESSURE; CARDIAC OUTPUT; CHARYBDOTOXIN; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FEMALE; FEMORAL ARTERY; HEME OXYGENASE (DECYCLIZING); ISOMETRIC CONTRACTION; LIVER CIRCULATION; LIVER FAILURE, ACUTE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE SYNTHASE; PHENYLEPHRINE; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SWINE; UP-REGULATION; VASCULAR RESISTANCE; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 33847209169     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520600930636     Document Type: Article

References (40)

1. Ellis A, Wendon J. Circulatory, respiratory, cerebral, and renal derangements in acute liver failure: pathophysiology and management. Semin Liver Dis 1996;16:379-88.
2. Trewby PN, Williams R. Pathophysiology of hypotension in patients with fulminant hepatic failure. Gut 1977;18:1021-6.
3. Balata S, Damink SW, Ferguson K, Marshall I, Hayes PC, Deutz NE, et al. Induced hyperammonemia alters neuropsychology, brain MR spectroscopy and magnetization transfer in cirrhosis. Hepatology 2003;37:931-9.
4. Schneider F, Lutun P, Boudjema K, Wolf P, Tempe JD. In vivo evidence of enhanced guanylyl cyclase activation during the hyperdynamic circulation of acute liver failure. Hepatology 1994;19:38-44.
5. Tabernero A, Schneider F, Potenza MA, Fidi-Soa Randriamboavonjy V, Chasserot S, Wolf P, et al. Cyclooxygenase-2 and inducible nitric oxide synthase in omental arteries harvested from patients with severe liver diseases: immuno-localization and influence on vascular tone. Intensive Care Med 2003;29:262-70.
6. Ytrebo LM, Nedredal GI, Langbakk B, Revhaug A. An experimental large animal model for the assessment of bioartificial liver support systems in fulminant hepatic failure. Scand J Gastroenterol 2002;37:1077-88.
7. Ytrebo LM, Ingebrigtsen T, Nedredal GI, Elvenes OP, Korvald C, Romner B, et al. Protein S-100beta: a biochemical marker for increased intracranial pressure in pigs with acute hepatic failure. Scand J Gastroenterol 2000;35:546-51.
8. Ytrebo LM, Nedredal GI, Korvald C, Holm Nielsen OJ, Ingebrigtsen T, Romner B, et al. Renal elimination of protein S-100beta in pigs with acute encephalopathy. Scand J Clin Lab Invest 2001;61:217-25.
9. Sen S, Rose C, Ytrebo LM, Davies NA, Nedredal GI, Drevland SS, et al. Effect of albumin dialysis on intracranial pressure increase in pigs with acute liver failure: a randomized study. Crit Care Med 2006;34:158-64.
10. Ytrebo LM, Ekse S, Sen S, Rose C, Nedredal GI, Fuskevag OM, et al. Contractile response of femoral arteries in pigs with acute liver failure. Scand J Gastroenterol 2004;39:1000-4.
11. Sen S, Ytrebo LM, Rose C, Fuskevaag OM, Davies NA, Nedredal GI, et al. Albumin dialysis: a new therapeutic strategy for intoxication from protein-bound drugs. Intensive Care Med 2004;30:496-501.
12. Busse R, Edwards G, Feletou M, Fleming I, Vanhoutte PM, Weston AH. EDHF: bringing the concepts together. Trends Pharmacol Sci 2002;23:374-80.
13. Bryan RM Jr, You J, Golding EM, Marrelli SP. Endothelium-derived hyperpolarizing factor: a cousin to nitric oxide and prostacyclin. Anesthesiology 2005;102:1261-77.
14. Chauhan SD, Hobbs AJ, Ahluwalia A. C-type natriuretic peptide: new candidate for endothelium-derived hyperpolarising factor. Int J Biochem Cell Biol 2004;36:1878-81.
15. + channels (BK(Ca)) in smooth muscle cells isolated from the rat mesenteric artery. Br J Pharmacol 1998;124:1131-40.
16. Tanaka Y, Yamaki F, Koike K, Toro L. New insights into the intracellular mechanisms by which PGI2 analogues elicit vascular relaxation: cyclic AMP-independent, Gs-protein mediated-activation of MaxiK channel. Curr Med Chem Cardiovasc Hematol Agents 2004;2:257-65.
17. Naik JS, Walker BR. Heme oxygenase-mediated vasodilation involves vascular smooth muscle cell hyperpolarization. Am J Physiol Heart Circ Physiol 2003;285:H220-8.
18. Chauhan S, Rahman A, Nilsson H, Clapp L, MacAllister R, Ahluwalia A. NO contributes to EDHF-like responses in rat small arteries: a role for NO stores. Cardiovasc Res 2003;57:207-16.
19. Ytrebo LM, Sen S, Rose C. Systemic and regional haemodynamics in pigs with acute liver failure and the effect of albumin dialysis. Scand J Gastroenterol 2006. In press.
20. Ytrebo LM, Korvald C, Nedredal GI, Elvenes OP, Nielsen Grymyr OJ, Revhaug A. N-acetylcysteine increases cerebral perfusion pressure in pigs with fulminant hepatic failure. Crit Care Med 2001;29:1989-95.
21. Berman RS, Martin PE, Evans WH, Griffith TM. Relative contributions of NO and gap junctional communication to endothelium-dependent relaxations of rabbit resistance arteries vary with vessel size. Microvasc Res 2002;63:115-28.
22. Tomioka H, Hattori Y, Fukao M, Sato A, Liu M, Sakuma I, et al. Relaxation in different-sized rat blood vessels mediated by endothelium-derived hyperpolarizing factor: importance of processes mediating precontractions. J Vasc Res 1999;36:311-20.
23. Urakami-Harasawa L, Shimokawa H, Nakashima M, Egashira K, Takeshita A. Importance of endothelium-derived hyperpolarizing factor in human arteries. J Clin Invest 1997;100:2793-9.
24. Stoen R, Lossius K, Karlsson JO. Acetylcholine-induced vasodilation may depend entirely upon NO in the femoral artery of young piglets. Br J Pharmacol 2003;138:39-46.
25. Smith RE, Robinson NM, McPeake JR, Baylis SA, Charles IG, Heaton ND, et al. Induction and role of NO synthase in hypotensive hepatic failure. Arterioscler Thromb Vasc Biol 1997;17:3079-82.
26. Kirstetter P, Moreau R, Vachiery F, Gadano A, Soupison T, Pilette C, et al. Plasma concentrations of cyclic 3′, 5′-guanosine monophosphate in patients with cirrhosis: relationship with atrial natriuretic peptide and haemodynamics. J Gastroenterol Hepatol 1997;12:233-6.
27. Corbalan R, Montoliu C, Minana MD, Del Olmo JA, Serra MA, Aparisi L, et al. Altered modulation of soluble guanylate cyclase by nitric oxide in patients with liver disease. Metab Brain Dis 2002;17:295-301.
28. Caraceni P, Van Thiel DH. Acute liver failure. Lancet 1995;345:163-9.
29. Rolando N,Wade J, Davalos M,Wendon J, Philpott-Howard J, Williams R. The systemic inflammatory response syndrome in acute liver failure. Hepatology 2000;32:734-9.
30. Koide M, Kawahara Y, Tsuda T, Nakayama I, Yokoyama M. Expression of nitric oxide synthase by cytokines in vascular smooth muscle cells. Hypertension 1994;23:I45-8.
31. Beasley D, Eldridge M. Interleukin-1 beta and tumor necrosis factor-alpha synergistically induce NO synthase in rat vascular smooth muscle cells. Am J Physiol 1994;266:R1197-203.
32. Wigmore SJ, Walsh TS, Lee A, Ross JA. Pro-inflammatory cytokine release and mediation of the acute phase protein response in fulminant hepatic failure. Intensive Care Med 1998;24:224-9.
33. Sekiyama KD, Yoshiba M, Thomson AW. Circulating proinflammatory cytokines (IL-1 beta, TNF-alpha, and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant hepatic failure and acute hepatitis. Clin Exp Immunol 1994;98:71-7.
34. Leifeld L, Fielenbach M, Dumoulin FL, Speidel N, Sauerbruch T, Spengler U. Inducible nitric oxide synthase (iNOS) and endothelial nitric oxide synthase (eNOS) expression in fulminant hepatic failure. J Hepatol 2002;37:613-9.
35. De las Heras D, Fernandez J, Gines P, Cardenas A, Ortega R, Navasa M, et al. Increased carbon monoxide production in patients with cirrhosis with and without spontaneous bacterial peritonitis. Hepatology 2003;38:452-9.
36. Fernandez M, Bonkovsky HL. Increased heme oxygenase-1 gene expression in liver cells and splanchnic organs from portal hypertensive rats. Hepatology 1999;29:1672-9.
37. Chen YC, Gines P, Yang J, Summer SN, Falk S, Russell NS, et al. Increased vascular heme oxygenase-1 expression contributes to arterial vasodilation in experimental cirrhosis in rats. Hepatology 2004;39:1075-87.
38. Maines MD. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 1997;37:517-54.
39. Cruse I, Maines MD. Evidence suggesting that the two forms of heme oxygenase are products of different genes. J Biol Chem 1988;263:3348-53.
40. French Institut National de la Recherche Agronomique. European Network for Pig Genomics (PIGNET) 2005:6.